Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04579614 · ClinicalTrials.gov registry record · NA
Performance Feedback in Health Care
A NA study, sponsored by Kaiser Permanente.
- Completed
- Registry status
- NA
- Development phase
- 595
- Enrollment target
NCT04579614: Completed NA study, sponsored by Kaiser Permanente.
NCT04579614 is a NA study that has completed, run by Kaiser Permanente. The registered enrollment target is 595 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (58% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04579614, a NA study, has completed, sponsored by Kaiser Permanente.
- COMPLETED
- Registry status
- NA
- Development phase
- 595 participants
- Enrollment target
Study Summary
The Southeast Permanente Medical Group (TSPMG) at Kaiser Permanente Georgia provides performance feedback to its providers. The performance feedback designs can vary and change over time in terms of targets, summary statistics, included measures, and frequency of delivery. The TSPMG health services research group seek to compare different performance feedback designs to identify which are most effective at contributing to performance improvement. The research team will randomly assign providers into different performance feedback conditions, as specified in the protocol. Providers will receive performance feedback through the standard mechanism in which it is conveyed by their supervisor. The objective is to investigate how to design performance feedback for providers to best motivate and support them in improving performance along with existing strategic priorities for care delivery. The reserach team will test alternative designs of performance feedback that vary on the following dimension: 1\) targets for comparison of one's own performance
Primary Outcome
Whether or not the providers succeeded in administering flu vaccination during flu vaccination opportunity
Interventions
- BEHAVIORAL The Impact of Performance Feedback and Variable Goal Setting on Flu Vaccination Success Rates of Providers
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 595 participants |
| Start Date | 2019-09-23 |
| Est. Completion | 2019-12-31 |
| Phase | NA |
What the finished NCT04579614 record still lists
NCT04579614 is an interventional study that assigns participants to a tested intervention. The registered 595 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (58% lower).
The record links to 0 conditions, and to 1 intervention - of which The Impact of Performance Feedback and Variable Goal Setting on Flu Vaccination Success Rates of Providers is the first listed.
NCT04579614 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04579614 about?
NCT04579614 is a clinical study titled "Performance Feedback in Health Care". The Southeast Permanente Medical Group (TSPMG) at Kaiser Permanente Georgia provides performance feedback to its providers. The performance feedback designs can vary and change over time in terms of targets, summary statistics, included measures, and frequency of delivery. The TSPMG health services ...
What is the current status of trial NCT04579614?
This trial is currently completed. It is a NA study. The enrollment target is 595 participants. The study started on 2019-09-23. Estimated completion is 2019-12-31.
What interventions are being tested in trial NCT04579614?
The interventions under investigation include: The Impact of Performance Feedback and Variable Goal Setting on Flu Vaccination Success Rates of Providers (BEHAVIORAL).
Who is sponsoring clinical trial NCT04579614?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04579614's enrollment target sits among peer trials
595 174th of 2000 higher than 1,827 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05723198 · 595 participants · Phase 3
A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata
- NCT02138734 · 596 participants · Phase 1
A Study of Intravesical BCG in Combination With ALT-803 in Patients With Non-Muscle Invasive Bladder Cancer
- NCT06797245 · 596 participants · NA
APPROVE Trial: Evaluating a Prescription Digital Therapeutic for Treatment of OAB in Women
- NCT07100080 · 596 participants · Phase 2
Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI